Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
03/2007
03/01/2007WO2007023503A1 A process for the preparation of fluvastatin sodium
03/01/2007WO2007022935A1 Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine d3 receptors
03/01/2007WO2007022845A1 Novel materials for organic electroluminescent devices
03/01/2007WO2007002181A3 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
03/01/2007WO2006135694A3 Uii-modulating compounds and their use
03/01/2007WO2006119104A3 Process for preparing isatins with control of side-product formation
03/01/2007WO2006036994A3 Modulators of crth2, cox-2 and faah
03/01/2007WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors
03/01/2007US20070049589 N-(4-{N'-[2-(6-Bromo-1H-indol-3-yl)-acetyl]-guanidinomethyl}-2,6-dichloro-phenyl)-acetamide, for example; useful in the treatment of neurological disorders related to beta-amyloid production, particularly, treatment of Alzheimer's Disease and similar diseases
03/01/2007US20070049536 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis
03/01/2007CA2619101A1 Immunosuppressant compounds and compositions
02/2007
02/28/2007EP1757585A1 Anionically substituted 7-Nitroindoline derivatives and their uses
02/28/2007EP1757584A1 Heterocyclic substituted amides, their production and their use
02/28/2007EP1757583A1 Process for producing cyclic n-hydroxyimide compound
02/28/2007EP1757292A1 Method of treating ocd and tic disorders
02/28/2007EP1757289A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
02/28/2007EP1756142A1 Pseudopeptides growth hormone secretagogues
02/28/2007EP1756112A1 Pyrrolobenzimidazolones and their use as antiproliferative agents
02/28/2007EP1756109A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
02/28/2007EP1756096A1 Indolyl derivatives as liver-x-receptor modulators
02/28/2007EP1756072A2 Purification of progesterone receptor modulators
02/28/2007EP1756063A1 Amido compounds and their use as pharmaceuticals
02/28/2007EP1756058A1 Histamine-3 receptor antagonists
02/28/2007EP1756057A1 Process for the preparation of carvedilol
02/28/2007EP1756056A1 Aza-bicyclo[3.1.0]hex-1-yl derivatives active as nk1 antagonists
02/28/2007EP1756055A1 Process for the purification of tryptophan
02/28/2007EP1756054A1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
02/28/2007EP1755593A1 Naphthaline derivatives useful as histamine-3-receptor ligands
02/28/2007EP1581538B1 Tetracyclic 3-substituted indoles having serotonin receptor affinity
02/28/2007EP1465893B1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) octane, the preparation thereof and the application of same in therapeutics
02/28/2007EP1343561B1 Serine protease inhibitors
02/28/2007EP1265606B9 Cell adhesion inhibitors
02/28/2007EP1240154B1 Serine protease inhibitors
02/28/2007EP1025077B1 Novel aryloxy-alkyl-dialkylamines
02/28/2007CN1922166A Method for the production of 3-amino-5-(hydroxymethyl)cyclopentane-1,2-diol derivatives
02/28/2007CN1922162A Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors
02/28/2007CN1922149A Pyrrole and pyrazole daao inhibitors
02/28/2007CN1922142A Oxime ester compound, photopolymerizable composition and color filter utilizing the same
02/28/2007CN1922141A Novel heterocyclic compound
02/28/2007CN1922140A Method for producing monatin
02/28/2007CN1921848A Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
02/28/2007CN1919842A Oxdiazole derivative and application thereof in electroluminescent material
02/28/2007CN1302339C Photo sensitive resin composition
02/28/2007CN1302116C Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative
02/28/2007CN1302029C Heterocyclic nitrogen-containing activators and catalyst systems for olefin polymerization
02/28/2007CN1302002C Hydroxylamine esters as polymerization initiators
02/28/2007CN1301971C Red organic electrofluorescence material based on N-aryl carbazole and its preparation method
02/28/2007CN1301970C 2,4-substituted indoles and their use as 5-HT6 modulators
02/28/2007CN1301963C Process for producing N-(4-fluobenzene radical)-N-(2-hydroxy-4-chlorobenzene group) glycocoll
02/27/2007US7183445 4-(4-Hydroxy-phenyl)-[4-(2-morpholin-4-yl-ethoxy)-benzyl]-methyl-cyclohex-3-enecarboxylic acid ethyl ester; estrogen receptor modulators for hot flashes, vaginal dryness, osteopenia, osteoporosis, hyperlipidemia, loss of cognitive function, degenerative brain diseases
02/27/2007US7183436 Substituted 4-aminocyclohexanols
02/27/2007US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/27/2007US7183309 Indole derivatives useful as progesterone receptor modulators
02/27/2007US7183308 Multistage process for forming perindopril from acid compound
02/27/2007US7183304 Heterocyclic compounds and methods of use
02/27/2007US7183298 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
02/27/2007US7183294 Indole derivatives useful for the treatment of diseases
02/27/2007US7183238 microbicides, pesticides and herbicides
02/27/2007US7182953 Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders
02/23/2007WO2007021308A1 Metabotropic glutamate-receptor-potentiating isoindolones
02/22/2007WO2007021309A1 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
02/22/2007WO2007020804A1 Arylamine compound and synthetic method thereof
02/22/2007WO2007020653A1 Thioether derivatives as functional 5-ht6 ligands
02/22/2007WO2007020009A1 New crystalline form of perindopril erbumine
02/22/2007WO2007000550A3 Novel indoline compounds
02/22/2007US20070043225 Method for the production of 3-amino-5-(hydroxymethyl) cyclopentane-1,2-diol-derivatives
02/22/2007US20070043104 UII-modulating compounds and their use
02/22/2007US20070043103 Novel metod for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
02/22/2007US20070043101 [4-({5-[(1,1'-biphenyl-4-ylsulfonyl)amino]-1H-indol-1-yl}methyl)phenoxy]acetic acid; inhibiting PAI-1 activity; treat impairment of the fibrinolytic system; thrombosis; cardiovascular disease; chronic obstructive pulmonary disease, renal fibrosis, polycystic ovary syndrome, Alzheimer's disease, cancer
02/22/2007US20070043100 Novel polymorphs of azabicyclohexane
02/22/2007US20070043099 Crystalline forms of carvedilol and processes for their preparation
02/22/2007US20070043041 Indol-6 sulfonamide derivative, their preparation and their use 5-ht-6 as modulators
02/22/2007US20070043038 Indolone-acetamide derivatives, processes for preparing them and their uses
02/22/2007US20070042968 Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease
02/22/2007US20070042109 Conversion of amine- to carboxyl groups on solid surfaces
02/22/2007CA2619659A1 Processes and intermediates
02/22/2007CA2618634A1 Compounds and compositions as tpo mimetics
02/22/2007CA2618516A1 New crystalline form of perindopril erbumine
02/22/2007CA2617372A1 Substituted indoles and use thereof
02/21/2007EP1754739A1 Deuterated polyimides and derivatives thereof
02/21/2007EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
02/21/2007EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
02/21/2007EP1754700A2 Synthesis of oligoketides
02/21/2007EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
02/21/2007EP1753763A2 Indazole and indolone derivatives and their use as pharmaceuticals
02/21/2007EP1753740A2 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
02/21/2007EP1753733A1 Small molecules for treatment of hypercholesterolemia and related diseases
02/21/2007EP1753720A1 Process for the preparation of perindopril and salts thereof
02/21/2007EP1753713A2 Synthesis of tetracyclines and analogues thereof
02/21/2007EP1753421A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
02/21/2007EP1519726B1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases
02/21/2007EP1511727B1 Aromatic sulfones and their medical use
02/21/2007EP1358156B1 Benz(g) indoles and their use as spla2 inhibitors
02/21/2007EP1000025B1 Substituted naphthopyrans
02/21/2007CN1918160A Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
02/21/2007CN1918122A Novel benzofurans and indols
02/21/2007CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same
02/21/2007CN1917921A Calcitonin gene related peptide receptor antagonists
02/21/2007CN1916760A Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition
02/21/2007CN1915995A S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method